Racial and Ethnic Disparities in Management and Outcomes of Cardiac Arrest Complicating Acute Myocardial Infarction.


Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
06 2021
Historique:
pubmed: 21 5 2021
medline: 26 10 2021
entrez: 20 5 2021
Statut: ppublish

Résumé

Background The role of race and ethnicity in the outcomes of cardiac arrest (CA) complicating acute myocardial infarction (AMI) is incompletely understood. Methods and Results This was a retrospective cohort study of adult admissions with AMI-CA from the National Inpatient Sample (2012-2017). Self-reported race/ethnicity was classified as White, Black, and others (Hispanic, Asian or Pacific Islander, Native American, Other). Outcomes of interest included in-hospital mortality, coronary angiography, percutaneous coronary intervention, palliative care consultation, do-not-resuscitate status use, hospitalization costs, hospital length of stay, and discharge disposition. Of the 3.5 million admissions with AMI, CA was noted in 182 750 (5.2%), with White, Black, and other races/ethnicities constituting 74.8%, 10.7%, and 14.5%, respectively. Black patients admitted with AMI-CA were more likely to be female, with more comorbidities, higher rates of non-ST-segment-elevation myocardial infarction, and higher neurological and renal failure. Admissions of patients of Black and other races/ethnicities underwent coronary angiography (61.9% versus 70.2% versus 73.1%) and percutaneous coronary intervention (44.6% versus 53.0% versus 58.1%) less frequently compared to patients of white race (

Identifiants

pubmed: 34013741
doi: 10.1161/JAHA.120.019907
pmc: PMC8483555
doi:

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e019907

Subventions

Organisme : NCATS NIH HHS
ID : TL1 TR001864
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000135
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Références

JAMA Cardiol. 2017 Sep 1;2(9):984-985
pubmed: 28793144
Resuscitation. 1999 Apr-May;40(3):141-6
pubmed: 10395396
Am J Public Health. 2000 Jul;90(7):1128-34
pubmed: 10897193
Int J Cardiol. 2020 Jul 1;310:9-15
pubmed: 32085862
Cardiovasc Diagn Ther. 2019 Feb;9(1):18-29
pubmed: 30881873
Heart. 2016 Sep 1;102(17):1363-70
pubmed: 27117723
Circ Cardiovasc Qual Outcomes. 2017 Jul;10(7):
pubmed: 28655709
Am J Cardiol. 2019 Aug 15;124(4):491-498
pubmed: 31221462
J Am Heart Assoc. 2021 Jan 19;10(2):e017693
pubmed: 33399018
J Am Coll Cardiol. 2019 Apr 2;73(12):1598-1600
pubmed: 30922482
JAMA. 2017 Nov 28;318(20):2011-2018
pubmed: 29183077
J Am Heart Assoc. 2019 Aug 6;8(15):e011954
pubmed: 31315497
Am J Cardiol. 2003 Oct 1;92(7):773-8
pubmed: 14516874
J Racial Ethn Health Disparities. 2020 Jun;7(3):403-412
pubmed: 31845289
N Engl J Med. 1997 Feb 13;336(7):480-6
pubmed: 9017942
Mayo Clin Proc. 2020 Mar;95(3):611-613
pubmed: 32138887
Fam Pract. 2011 Oct;28(5):505-15
pubmed: 21596693
Am Heart J. 2020 May;223:59-64
pubmed: 32163754
J Am Heart Assoc. 2018 Nov 20;7(22):e010193
pubmed: 30571481
J Clin Med. 2020 Aug 22;9(9):
pubmed: 32842643
Circ Heart Fail. 2019 Nov;12(11):e006635
pubmed: 31707801
Ann Intern Med. 2001 Sep 4;135(5):352-66
pubmed: 11529699
N Engl J Med. 2013 Mar 14;368(11):1019-26
pubmed: 23484828
ESC Heart Fail. 2020 Jun;7(3):1234-1245
pubmed: 32239806
JAMA. 1993 May 26;269(20):2642-6
pubmed: 8487447
Int J Cardiol. 2019 Jun 15;285:6-10
pubmed: 30871802
ESC Heart Fail. 2019 Aug;6(4):874-877
pubmed: 31271517
Am J Cardiol. 2020 Jun 15;125(12):1774-1781
pubmed: 32307093
Med Care. 2005 Apr;43(4):308-19
pubmed: 15778634
Circulation. 2005 Mar 15;111(10):1225-32
pubmed: 15769762
J Am Heart Assoc. 2021 Jun;10(11):e019907
pubmed: 34013741
Crit Care Med. 2013 Dec;41(12):2784-93
pubmed: 24121467
Med Care. 2005 Nov;43(11):1130-9
pubmed: 16224307
Resuscitation. 2015 Feb;87:69-74
pubmed: 25497394
JAMA. 2009 Sep 16;302(11):1195-201
pubmed: 19755698
JAMA. 1994 Apr 20;271(15):1175-80
pubmed: 8151875
JAMA. 2012 Nov 7;308(17):1768-74
pubmed: 23117777
Health Serv Res. 2008 Aug;43(4):1388-402
pubmed: 18355259
Eur J Prev Cardiol. 2014 May;21(5):619-38
pubmed: 22692471
Am J Public Health. 2016 Jun;106(6):1049-51
pubmed: 27077357
J Clin Med. 2020 Aug 12;9(8):
pubmed: 32806620
Prehosp Emerg Care. 2020 Jul-Aug;24(4):544-549
pubmed: 31613657
J Am Coll Cardiol. 2019 Apr 16;73(14):1781-1791
pubmed: 30975295
Am Heart J. 2011 Apr;161(4):705-11
pubmed: 21473969
JAMA Cardiol. 2017 Sep 1;2(9):976-984
pubmed: 28793138
EuroIntervention. 2021 Feb 05;16(15):e1254-e1261
pubmed: 31746759
Emerg Med J. 2012 May;29(5):415-9
pubmed: 21546508

Auteurs

Anna V Subramaniam (AV)

Department of Medicine Mayo Clinic Rochester MN.

Sri Harsha Patlolla (SH)

Department of Cardiovascular Surgery Mayo Clinic Rochester MN.

Wisit Cheungpasitporn (W)

Division of Nephrology and Hypertension Department of Medicine Mayo Clinic Rochester MN.

Pranathi R Sundaragiri (PR)

Division of Hospital Internal Medicine Department of Medicine Mayo Clinic Rochester MN.

P Elliott Miller (PE)

Division of Cardiovascular Medicine Department of Medicine Yale University School of Medicine New Haven CT.

Gregory W Barsness (GW)

Department of Cardiovascular Medicine Mayo Clinic Rochester MN.

Malcolm R Bell (MR)

Department of Cardiovascular Medicine Mayo Clinic Rochester MN.

David R Holmes (DR)

Department of Cardiovascular Medicine Mayo Clinic Rochester MN.

Saraschandra Vallabhajosyula (S)

Department of Cardiovascular Medicine Mayo Clinic Rochester MN.
Division of Pulmonary and Critical Care Medicine Department of Medicine Mayo Clinic Rochester MN.
Center for Clinical and Translational Science Mayo Clinic Graduate School of Biomedical Sciences Rochester MN.
Section of Interventional Cardiology Division of Cardiovascular Medicine Department of Medicine Emory University School of Medicine Atlanta GA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH